Latest Insider Transactions at Biodelivery Sciences International Inc (BDSI)
This section provides a real-time view of insider transactions for Biodelivery Sciences International Inc (BDSI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIODELIVERY SCIENCES INTERNATIONAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIODELIVERY SCIENCES INTERNATIONAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
Jeffrey Allen Bailey Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
105,133
-100.0%
|
-
|
|
Mar 22
2022
|
Todd C Davis Director |
SELL
Other acquisition or disposition
|
Direct |
252,207
-100.0%
|
-
|
|
Mar 22
2022
|
Peter Greenleaf Director |
SELL
Other acquisition or disposition
|
Direct |
105,034
-100.0%
|
-
|
|
Mar 22
2022
|
Kevin Kotler Director |
SELL
Other acquisition or disposition
|
Indirect |
7,588,395
-100.0%
|
-
|
|
Mar 22
2022
|
Scott M. Plesha Officer |
SELL
Other acquisition or disposition
|
Direct |
345,127
-100.0%
|
-
|
|
Mar 22
2022
|
Mark A Sirgo Director |
SELL
Other acquisition or disposition
|
Direct |
1,166,866
-100.0%
|
-
|
|
Mar 22
2022
|
Thomas B Smith Chief Medical Officer |
SELL
Other acquisition or disposition
|
Direct |
52,530
-100.0%
|
-
|
|
Mar 22
2022
|
Vanila Singh Director |
SELL
Other acquisition or disposition
|
Direct |
35,851
-100.0%
|
-
|
|
Mar 22
2022
|
W. Mark Watson Director |
SELL
Other acquisition or disposition
|
Direct |
90,663
-100.0%
|
-
|
|
Mar 09
2022
|
Jeffrey Allen Bailey Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,333
+4.83%
|
-
|
|
Feb 11
2022
|
Kevin Kotler Director |
BUY
Conversion of derivative security
|
Indirect |
2,422,222
+24.2%
|
$2,422,222
$1.8 P/Share
|
|
Feb 04
2022
|
James Vollins Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,872
-100.0%
|
$29,616
$3.66 P/Share
|
|
Feb 04
2022
|
James Vollins Officer |
SELL
Open market or private sale
|
Direct |
18,541
-65.26%
|
$55,623
$3.6 P/Share
|
|
Jan 31
2022
|
Scott M. Plesha Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,203
+3.45%
|
-
|
|
Jan 31
2022
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,137
+18.57%
|
-
|
|
Jan 31
2022
|
Thomas B Smith Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,215
+13.57%
|
-
|
|
Jan 27
2022
|
Todd C Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+2.96%
|
-
|
|
Jan 27
2022
|
Scott M. Plesha Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,050
+6.16%
|
-
|
|
Jan 27
2022
|
James Vollins Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,276
+50.0%
|
-
|
|
Jan 27
2022
|
Thomas B Smith Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,361
+31.75%
|
-
|
|
Jan 27
2022
|
Peter Greenleaf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,246
+8.89%
|
-
|
|
Jan 27
2022
|
Kevin Kotler Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,684
+0.15%
|
-
|
|
Jan 27
2022
|
Mark A Sirgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+0.65%
|
-
|
|
Jan 27
2022
|
Vanila Singh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+17.65%
|
-
|
|
Jan 27
2022
|
W. Mark Watson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,684
+7.81%
|
-
|
|
Dec 02
2021
|
Mark A Sirgo Director |
BUY
Open market or private purchase
|
Direct |
18,587
+1.58%
|
$37,174
$2.69 P/Share
|
|
Nov 22
2021
|
Vanila Singh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,333
+15.92%
|
-
|
|
Nov 19
2021
|
Kevin Kotler Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.9%
|
$300,000
$3.06 P/Share
|
|
Nov 18
2021
|
Mark A Sirgo Director |
BUY
Open market or private sale
|
Direct |
10,000
+0.87%
|
$30,000
$3.04 P/Share
|
|
Nov 12
2021
|
Kevin Kotler Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.94%
|
$300,000
$3.2 P/Share
|
|
Nov 11
2021
|
Mark A Sirgo Director |
BUY
Open market or private purchase
|
Direct |
16,000
+1.4%
|
$48,000
$3.2 P/Share
|
|
Nov 05
2021
|
Kevin Kotler Director |
BUY
Open market or private purchase
|
Indirect |
257,800
+4.94%
|
$773,400
$3.47 P/Share
|
|
Nov 04
2021
|
Jeffrey Allen Bailey Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,333
+34.83%
|
-
|
|
Aug 23
2021
|
Mark A Sirgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+0.36%
|
-
|
|
Aug 23
2021
|
Vanila Singh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+14.91%
|
-
|
|
Aug 10
2021
|
Kevin Kotler Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
15,000
+0.32%
|
$30,000
$2.93 P/Share
|
|
Aug 06
2021
|
Todd C Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+10.93%
|
-
|
|
Aug 06
2021
|
Peter Greenleaf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+26.97%
|
-
|
|
Aug 06
2021
|
Kevin Kotler Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
30,000
+0.64%
|
-
|
|
Aug 06
2021
|
W. Mark Watson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+26.55%
|
-
|
|
Aug 06
2021
|
Jeffrey Allen Bailey Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,567
+10.7%
|
-
|
|
Aug 06
2021
|
Mark A Sirgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+0.36%
|
-
|
|
Aug 06
2021
|
Vanila Singh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,750
+26.38%
|
-
|
|
May 13
2021
|
Mark A Sirgo Director |
BUY
Open market or private purchase
|
Direct |
3,000
+0.27%
|
$9,000
$3.16 P/Share
|
|
May 13
2021
|
Kevin Kotler Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.06%
|
$150,000
$3.25 P/Share
|
|
May 12
2021
|
Mark A Sirgo Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.45%
|
$15,000
$3.24 P/Share
|
|
May 12
2021
|
Kevin Kotler Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.13%
|
$300,000
$3.24 P/Share
|
|
May 11
2021
|
Mark A Sirgo Director |
BUY
Open market or private purchase
|
Direct |
7,500
+0.68%
|
$22,500
$3.16 P/Share
|
|
May 11
2021
|
Kevin Kotler Director |
BUY
Open market or private purchase
|
Indirect |
150,000
+3.22%
|
$450,000
$3.16 P/Share
|
|
Mar 12
2021
|
Scott M. Plesha Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,834
+6.5%
|
-
|